Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations

Research output: Contribution to journal › Article › Academic › peer-review

54 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2811-2829
Journal	Current pharmaceutical design
Volume	18
Issue number	19
DOIs	https://doi.org/10.2174/138161212800626175
Publication status	Published - 2012

Access to Document

@article{ac2e52033d744ee2b9a7563917acf9bc,

title = "Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations",

author = "M. Elnaggar and E. Giovannetti and G.J. Peters",

year = "2012",

doi = "https://doi.org/10.2174/138161212800626175",

language = "Undefined/Unknown",

volume = "18",

pages = "2811--2829",

journal = "Current pharmaceutical design",

issn = "1381-6128",

publisher = "Bentham Science Publishers B.V.",

number = "19",

}

TY - JOUR

T1 - Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations

AU - Elnaggar, M.

AU - Giovannetti, E.

AU - Peters, G.J.

PY - 2012

Y1 - 2012

U2 - https://doi.org/10.2174/138161212800626175

DO - https://doi.org/10.2174/138161212800626175

M3 - Article

SN - 1381-6128

VL - 18

SP - 2811

EP - 2829

JO - Current pharmaceutical design

JF - Current pharmaceutical design

IS - 19

ER -